The STING of death in T cells

September 5, 2017

The cells of the innate immune system use a signaling pathway comprising STING (Stimulator of interferon genes) to detect DNA from invading viruses and fight them. However, it is unknown if STING triggers the same or different responses in cells of the adaptive immune system, such as T cells. EPFL scientists have now shown that T cells have an "unconventional" STING response, which manifests as apoptotic cell death. The work, which may have implications for the treatment T cell-derived malignancies, is published in Nature Communications.

Innate immune system

The innate immune system is our first line of defense, made up of that quickly identify pathogens such as DNA from viruses. To do this, these cells use receptors that can identify nucleic acids—the building blocks of DNA—that in turn activate a signaling molecule called STING.

Once activated, the STING turns on a set of genes that produce signaling molecules (cytokines) that help cells communicate with each other, as well as other cell-activating processes that fight off the infecting pathogen. But what we don't know whether the STING response produces different outcomes between different cell types.

The STING of death

The lab of Andrea Ablasser at EPFL looked at the consequences of the STING pathway in T cells. Their analysis found that STING triggers the expression of BH3-only proteins—well known to be involved in cell death—which induces apoptosis in cells, as opposed to the production of cytokines such as interferons, which stimulate immune responses.

Interestingly, the researchers also found that this pro-apoptotic effect exists in cancerous T cells, such as the ones that cause T-cell lymphomas, which account for about a tenth of non-Hodgkin lymphomas. The EPFL scientists found that delivering a small molecule that activates the STING pathway prevents the growth of T cell-derived tumors in live animals.

The work shows an unanticipated connection between the magnitude of STING signaling and its ability to elicit different responses. This may allow for cell-type-adjusted behaviors in the presence of internal or external insults such as infections or oxidative stress.

The study uncovers a novel, non-immune effect of the STING pathway whereby it induces a different effect in cells of the adaptive immune system (T cells) than its effect in cells of the innate immune system. The fact that this effect is pro-apoptotic and is maintained even in cancerous T cells in vivo open up significant possibilities for treating T-cell lymphomas in the future.

Explore further: Cell senescence is regulated by innate DNA sensing

More information: Muhammet F. Gulen et al, Signalling strength determines proapoptotic functions of STING, Nature Communications (2017). DOI: 10.1038/s41467-017-00573-w

Related Stories

Cell senescence is regulated by innate DNA sensing

July 31, 2017
Cells in the body or in cultures eventually stop replicating. This phenomenon is called "senescence" and is triggered by shortening of telomeres, oxidative stress or genetic damage to the cells, either acute or simply due ...

Danish discovery opens up for new type of immunological treatment of cancer

February 21, 2017
Researchers from Aarhus University have found an important piece of the puzzle leading towards an understanding of how our innate immune system reacts against viral infections and recognises foreign DNA, for example from ...

Researchers describe role of STING protein in development of colorectal cancer

January 1, 2016
A new study published today by researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine (Sylvester) reports on a key finding about the immune system's response to tumor development ...

New class of drugs specifically induces cell death in B cell blood cancers

March 10, 2016
In almost every mammalian cell, you will find the endoplasmic reticulum, a network of continuous membranes responsible for controlling metabolism as well as the folding, assembly and secretion of proteins. Since the endoplasmic ...

Novel immunotherapy approach shows promise in blood cancers

June 2, 2016
A protein known as STING plays a crucial role in the immune system's ability to "sense" cancer by recognizing and responding to DNA from tumor cells. Injection of compounds that activate the STING pathway directly into solid ...

Every step you take: STING pathway key to tumor immunity

November 20, 2014
A recently discovered protein complex known as STING plays a crucial role in detecting the presence of tumor cells and promoting an aggressive anti-tumor response by the body's innate immune system, according to two separate ...

Recommended for you

Exposure to pet and pest allergens during infancy linked to reduced asthma risk

September 19, 2017
Children exposed to high indoor levels of pet or pest allergens during infancy have a lower risk of developing asthma by 7 years of age, new research supported by the National Institutes of Health reveals. The findings, published ...

MicroRNA helps cancer evade immune system

September 18, 2017
The immune system automatically destroys dysfunctional cells such as cancer cells, but cancerous tumors often survive nonetheless. A new study by Salk scientists shows one method by which fast-growing tumors evade anti-tumor ...

'Exciting' discovery on path to develop new type of vaccine to treat global viruses

September 15, 2017
Scientists at the University of Southampton have made a significant discovery in efforts to develop a vaccine against Zika, dengue and Hepatitis C viruses that affect millions of people around the world.

Regular exercise, stress can both make a big difference in lupus, study finds

September 13, 2017
Waking up in the morning with the joint pain, swelling and stiffness that accompanies lupus doesn't exactly inspire a workout.

New research shows asthma drug's effectiveness over usual care alone

September 13, 2017
A new study co-authored by the University of Plymouth and published in The Lancet shows how an asthma drug was more effective at improving a patient's asthma control compared with their usual care.

Study reveals new clues to how a successful HIV vaccine could work

September 12, 2017
Scientists at The Scripps Research Institute (TSRI) have made a discovery that could speed efforts to develop a successful HIV vaccine.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.